GENTOX

MEDICAL SERVICES

Start with These People:

• PHARMACOGENETICS (DNA) TESTING: o ALL Medicare/Geriatric Patients. Especially Multi-Pharmacy Patients. o Anyone you feel are not getting the full results of drug regiments like you

thought they should. o Anyone experiencing Adverse Reactions, Side Effects or Allergic Reactions. o Anyone Taking Major Medications during Pregnancy. o Anyone that is Nervous about taking medications.

• URIN/SALIVA DRUG TESTING (UDT), TOXICOLOGY: o All Patients taking any kind of Pain or Psychotropic Medication. o Patients experiencing uncomfortable side effects to their medications. o High Risk Patients should be 2-4 times a month, Moderate Risk Patients 2-4

times a quarter, Low Risk 2-4 times a year.

• HEREDITARY CANCER TESTING: o ALL Patients with any kind of Cancer or rare Disease History within their

immediate family.

• ALLERGY: o ALL Patients experiencing airborne allergies. o ALL Patients who are on constant allergy medications and experience continual

congestion.

• HPV TEST AND/OR PAP SMEARS: o All women over the age of 25. o CT/NG TESTING (Chlamydia/Gonorrhea). o VAGINOSIS PANEL (Cadida, Gardnerella, Trichomonas).

• WHOLE GENOME CHROMOSOMAL MICROARRAY ANALYSIS o Unexplained developmental delay/intellectual disability. o Autism or Autism Spectrum Disorder. o Developmental or Learning Problems, or Growth Abnormalities. o Dysmorphic Features, Birth Defects, or Multiple Congenital Anomalies. o Seizure Disorder or Hypotonia. o Uniparental Disomy or conditions resulting from shared Parental Ancestry

(Consanguinity).

FRAGILE X DNA ANALYSIS

o Unexplained developmental delay/intellectual disability. o Autism or Autism Spectrum Disorder. o Developmental or Learning Problems, or Growth Abnormalities. o Cytogenetic findings consistent with FXS. o Adult-onset Tremor/Ataxia. o Female infertility associated with elevated follicle-stimulated (FSH) or Primary

Ovarian Insufficiency. • CYSTIC FIBROSIS CF-139 PANEL:

o Carrier o All women of child-bearing age regardless of race or ethnicity. o Individuals or Couples with a positive family history of CF.

o Diagnostic o Suspected or known diagnosis of CF. o Congenital absence of the Vas Deferens (CAVD, males).

• C-VRAS – CARDIO-VASCULAR RISK ASSESSMENT o ALL WOMEN that had any level of Preeclampsia during pregnancy.

• PATERNITY TESTING o Court Admissible Test. o Personal Use Screen.

• OARS ASSESMENT TOOL o ALL patients at the onset of using the tool. o All New patients.